Relating to the sale of certain abusable synthetic substances; providing a civil penalty.
If enacted, the legislation will amend the Health and Safety Code by adding Chapter 484, which introduces definitions for 'abusable synthetic substances' and outlines prohibited acts related to their sale. Individuals or businesses found selling these substances, with knowledge of their effects, could face significant financial penalties, with amounts not exceeding $10,000 for each violation. This approach is intended to deter the sale of harmful substances that could otherwise proliferate under the current regulatory framework.
House Bill 1323 aims to regulate the sale of certain abusable synthetic substances by establishing civil penalties for violations. The bill specifically addresses substances that are not classified under existing state or federal laws but produce effects similar to controlled substances when introduced into the body. The intent behind the bill is to close loopholes in the regulation of emerging synthetic drugs that mimic the effects of known illicit substances, thus enhancing public health and safety.
There may be varying opinions on the bill's implications for business practices, particularly among vendors who may inadvertently be caught selling these substances without knowing their effects. Concern over overregulation and potential impacts on legitimate businesses could emerge during discussions of the bill. Furthermore, the bill allows for local or state attorneys to initiate civil actions for penalties, emphasizing its enforcement aspects but potentially raising questions about resource allocation for enforcement and compliance.
The last recorded action on HB 1323 was a referral to the Public Health committee on March 5, 2015, indicating that the bill is in the legislative process where further discussion and possible amendments may take place.